KLACID 125MG/5ML suukaudse suspensiooni graanulid Estonija - estonski - Ravimiamet

klacid 125mg/5ml suukaudse suspensiooni graanulid

abbvie s.r.l. - klaritromütsiin - suukaudse suspensiooni graanulid - 25mg 1ml 60ml 1tk; 25mg 1ml 100ml 1tk

Xenpozyme Europska Unija - estonski - EMA (European Medicines Agency)

xenpozyme

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - muud alimentary seedetrakti ja ainevahetust tooted, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.

Aqumeldi Europska Unija - estonski - EMA (European Medicines Agency)

aqumeldi

proveca pharma limited - enalapril (maleate) - südamepuudulikkus - reniini-angiotensiini süsteemi toimivad ained - treatment of heart failure.

TARKA toimeainet modifitseeritult vabastav tablett Estonija - estonski - Ravimiamet

tarka toimeainet modifitseeritult vabastav tablett

bgp products sia - trandolapriil+verapamiil - toimeainet modifitseeritult vabastav tablett - 2mg+240mg 98tk; 2mg+240mg 50tk; 2mg+240mg 30tk; 2mg+240mg 28tk

Deltyba Europska Unija - estonski - EMA (European Medicines Agency)

deltyba

otsuka novel products gmbh - delamanid - tuberkuloos, multidrug-resistentne - antimükobakterid - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 ja 5. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.

Segluromet Europska Unija - estonski - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

SUDAFED BRONCHO HONEY & LEMON 20MG/ML siirup Estonija - estonski - Ravimiamet

sudafed broncho honey & lemon 20mg/ml siirup

mcneil products limited - guaifenesiin - siirup - 20mg 1ml 150ml 1tk

Aclasta Europska Unija - estonski - EMA (European Medicines Agency)

aclasta

sandoz pharmaceuticals d.d. - zoledroonhape - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - narkootikumid luuhaiguste raviks - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. ravi osteoporoosi seotud pikaajalise süsteemse glükokortikoidi ravi post-menopausis naistel ja meestel suurenenud risk luumurdude. ravi paget tõbi, luu.